These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10195066)

  • 1. DNase in cystic fibrosis: the challenge of assessing response and maximising benefit.
    Innes JA
    Thorax; 1998 Dec; 53(12):1003-4. PubMed ID: 10195066
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cystic fibrosis: current therapy. Inhalation therapy with recombinant DNAse].
    Rutishauser M
    Schweiz Med Wochenschr Suppl; 2000; 122():47S-48S. PubMed ID: 12536474
    [No Abstract]   [Full Text] [Related]  

  • 3. Which DNAse in cystic fibrosis?
    Morice AH
    Lancet; 1993 Sep; 342(8871):624-5. PubMed ID: 8102760
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problems.
    Zach MS
    Thorax; 1996 Jul; 51(7):750-5. PubMed ID: 8882085
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant human DNase in cystic fibrosis.
    Milla CE
    Lancet; 1999 Jul; 354(9176):428. PubMed ID: 10437902
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study.
    Aitken ML; Burke W; McDonald G; Shak S; Montgomery AB; Smith A
    JAMA; 1992 Apr; 267(14):1947-51. PubMed ID: 1548827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNase trials in cystic fibrosis.
    Hodson ME; Shah PL
    Eur Respir J; 1995 Oct; 8(10):1786-91. PubMed ID: 8586138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cystic fibrosis: molecular aspects and therapeutic prospects].
    Mazza P
    Boll Chim Farm; 1994 Jan; 133(1):35-8. PubMed ID: 8166964
    [No Abstract]   [Full Text] [Related]  

  • 9. Placebo-controlled n-of-1 trials in cystic fibrosis.
    Mitchell I; Doig CJ
    Eur Respir J; 1999 Oct; 14(4):993; author reply 994. PubMed ID: 10573256
    [No Abstract]   [Full Text] [Related]  

  • 10. Nuclease therapeutics in the clinic.
    Edgington SM
    Biotechnology (N Y); 1993 May; 11(5):580-2. PubMed ID: 7763605
    [No Abstract]   [Full Text] [Related]  

  • 11. The efficacy/cost ratio of new therapy. What is the physician's fiduciary responsibility?
    Pingleton SK
    Chest; 1994 Feb; 105(2):329-30. PubMed ID: 8306717
    [No Abstract]   [Full Text] [Related]  

  • 12. Placebo-controlled n-of-1 trials in cystic fibrosis.
    Webb S; Tansey P; Brown H; Jackson A; Bilton D
    Eur Respir J; 1999 Oct; 14(4):993; author reply 994. PubMed ID: 10573255
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost of care for individuals with cystic fibrosis: a regression approach to determining the impact of recombinant human DNase.
    Johnson JA; Connolly MA; Jacobs P; Montgomery M; Brown NE; Zuberbuhler P
    Pharmacotherapy; 1999 Oct; 19(10):1159-66. PubMed ID: 10512065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1994 Feb; 271(7):494. PubMed ID: 8301750
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cystic fibrosis. Current indications for nebulized treatments: antibiotics and DNase].
    Sardet-Frismand A
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S131-2. PubMed ID: 10088286
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term effects of aerosolised rhDNase on pulmonary disease progression in patients with cystic fibrosis.
    Milla CE
    Thorax; 1998 Dec; 53(12):1014-7. PubMed ID: 10195070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cystic fibrosis: time for a new paradigm?
    Bush A
    Chest; 2009 Nov; 136(5):1197-1199. PubMed ID: 19892669
    [No Abstract]   [Full Text] [Related]  

  • 18. Question 2: should hypertonic saline be used in patients with cystic fibrosis who respond unsatisfactorily to recombinant deoxyribonuclease?
    Badurdeen S; Ross-Russell R
    Arch Dis Child; 2010 Jul; 95(7):562-4. PubMed ID: 20551202
    [No Abstract]   [Full Text] [Related]  

  • 19. DNase in stable cystic fibrosis infants: a pilot study.
    Berge MT; Wiel Ev; Tiddens HA; Merkus PJ; Hop WC; de Jongste JC
    J Cyst Fibros; 2003 Dec; 2(4):183-8. PubMed ID: 15463871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No positive effect of rhdnase on the pulmonary colonization in children with cystic fibrosis.
    Bonestroo HJ; Slieker MG; Arets HG
    Monaldi Arch Chest Dis; 2010 Mar; 73(1):12-7. PubMed ID: 20499789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.